Staphylococcus Aureus Infection
25
4
8
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 25 trials
100.0%
+13.5% vs benchmark
20%
5 trials in Phase 3/4
18%
2 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (25)
Staph Intervention for Effective Local Defense
Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections
Immune Resolution After Staphylococcus Aureus Bacteremia
Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study
Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection
Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial
Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia
Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections
Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis
Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
Nasal Decolonization of Dialysis Patients Noses
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers
A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection
Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus
Recurrent S. Aureus Infections in Osteoarticular Infections
A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
Livestock Contact and MRSA in Rural Areas